i recall NDAs being in place years ago...nader said so explicitly and implied that these NDAs allowed these BPs to access all data of trials. if these NDAs were in place years ago that means there were serious enough negotiations to warrant said NDAs, years ago. otherwise why would cytodyn allow any BP have access to data? seems a BP would need to indicate fairly serious interest in partnership / BO in order for a small biotech to hand over such sensitive data...?

also perplexing that if a BP were in NDA with access to data, what is the actual punishment for breaking this NDA? seems like the stock movement of the last few weeks was clearly a result of inside info, particularly of the hold actually being lifted that we were not informed of until the 14th.


but what do i know.

Quote:

---

If memory serves, the company's IR has acknowledged that there are (or were) NDAs in place. I don't believe anything that Dr. Jay told us in the CC shed any light on those NDAs. Doesn't this mean that there possible partnership projects that were and still are waiting in the wings? If not, does anyone have a clue about what else could those NDAs cover?

Read More: https://investorshangout.com/post/newpost/605...z8M7E9CXV6

---